Literature DB >> 31000459

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

Rachel W Kubiak1, Leila R Zelnick2, Andy N Hoofnagle3, Charles E Alpers4, Christi M Terry5, Yan-Ting Shiu5, Alfred K Cheung5, Ian H de Boer2, Cassianne Robinson-Cohen2, Michael Allon6, Laura M Dember7, Harold I Feldman8, Jonathan Himmelfarb2, Thomas S Huber9, Prabir Roy-Chaudhury10, Miguel A Vazquez11, John W Kusek12, Gerald J Beck13, Peter B Imrey14, Bryan Kestenbaum2.   

Abstract

BACKGROUND: The arteriovenous fistula (AVF) is central to haemodialysis treatment, but up to half of surgically created AVF fail to mature. Chronic kidney disease often leads to mineral metabolism disturbances that may interfere with AVF maturation through adverse vascular effects. This study tested associations between mineral metabolism markers and vein histology at AVF creation and unassisted and overall clinical AVF maturation.
METHODS: Concentrations of fibroblast growth factor 23, parathyroid hormone, calcium, phosphate, and vitamin D metabolites: 1,25(OH)2D, 24,25(OH)2D, 25(OH)D, and bioavailable 25(OH)D were measured in pre-operative serum samples from 562 of 602 participants in the Haemodialysis Fistula Maturation Study, a multicentre, prospective cohort study of patients undergoing surgical creation of an autologous upper extremity AVF. Unassisted and overall AVF maturation were ascertained for 540 and 527 participants, respectively, within nine months of surgery or four weeks of dialysis initiation. Study personnel obtained vein segments adjacent to the portion of the vein used for anastomosis, which were processed, embedded, and stained for measurement of neointimal hyperplasia, calcification, and collagen deposition in the medial wall.
RESULTS: Participants in this substudy were 71% male, 43% black, and had a mean age of 55 years. Failure to achieve AVF maturation without assistance occurred in 288 (53%) participants for whom this outcome was determined. In demographic and further adjusted models, mineral metabolism markers were not significantly associated with vein histology characteristics, unassisted AVF maturation failure, or overall maturation failure, other than a biologically unexplained association of higher 24,25(OH)2D with overall failure. This exception aside, associations were non-significant for continuous and categorical analyses and relevant subgroups.
CONCLUSIONS: Serum concentrations of measured mineral metabolites were not substantially associated with major histological characteristics of veins in patients undergoing AVF creation surgery, or with AVF maturation failure, suggesting that efforts to improve AVF maturation rates should increase attention to other processes such as vein mechanics, anatomy, and cellular metabolism among end stage renal disease patients.
Copyright © 2019 European Society for Vascular Surgery. All rights reserved.

Entities:  

Keywords:  Arteriovenous fistula; Chronic kidney disease; Haemodialysis; Mineral metabolism; Vein histology; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 31000459      PMCID: PMC7259372          DOI: 10.1016/j.ejvs.2019.01.022

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  33 in total

1.  Objectives and design of the hemodialysis fistula maturation study.

Authors:  Laura M Dember; Peter B Imrey; Gerald J Beck; Alfred K Cheung; Jonathan Himmelfarb; Thomas S Huber; John W Kusek; Prabir Roy-Chaudhury; Miguel A Vazquez; Charles E Alpers; Michelle L Robbin; Joseph A Vita; Tom Greene; Jennifer J Gassman; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2013-08-28       Impact factor: 8.860

2.  Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access.

Authors:  M F Weiss; V Scivittaro; J M Anderson
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

Review 3.  Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.

Authors:  Kailash Jindal; Christopher T Chan; Clement Deziel; David Hirsch; Steven D Soroka; Marcello Tonelli; Bruce F Culleton
Journal:  J Am Soc Nephrol       Date:  2006-03       Impact factor: 10.121

Review 4.  Role of vitamin D in atherosclerosis.

Authors:  Eva Kassi; Christos Adamopoulos; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Circulation       Date:  2013-12-03       Impact factor: 29.690

5.  Effects of intraoperative blood flow on the early patency of radiocephalic fistulas.

Authors:  T Won; J W Jang; S Lee; J J Han; Y S Park; J H Ahn
Journal:  Ann Vasc Surg       Date:  2000-09       Impact factor: 1.466

6.  Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).

Authors:  Sharon M Moe; Martina Reslerova; Markus Ketteler; Kalisha O'neill; Danxia Duan; Jacob Koczman; Ralf Westenfeld; Willi Jahnen-Dechent; Neal X Chen
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

7.  Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Authors:  Charles E Alpers; Peter B Imrey; Kelly L Hudkins; Tomasz A Wietecha; Milena Radeva; Michael Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Yan-Ting Shiu; Christi M Terry; Alik Farber; Gerald J Beck; Harold I Feldman; John W Kusek; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2017-07-19       Impact factor: 10.121

8.  Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael C Sachs; Abigail Shoben; Gregory P Levin; Cassy Robinson-Cohen; Andrew N Hoofnagle; Nancy Swords-Jenny; Joachim H Ix; Matthew Budoff; Pamela L Lutsey; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Am J Clin Nutr       Date:  2013-04-24       Impact factor: 7.045

9.  Cellular phenotypes in human stenotic lesions from haemodialysis vascular access.

Authors:  Prabir Roy-Chaudhury; Yang Wang; Mahesh Krishnamoorthy; Jianhua Zhang; Rupak Banerjee; Rino Munda; Sue Heffelfinger; Lois Arend
Journal:  Nephrol Dial Transplant       Date:  2009-04-17       Impact factor: 5.992

10.  Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Authors:  Orlando M Gutiérrez; James L Januzzi; Tamara Isakova; Karen Laliberte; Kelsey Smith; Gina Collerone; Ammar Sarwar; Udo Hoffmann; Erin Coglianese; Robert Christenson; Thomas J Wang; Christopher deFilippi; Myles Wolf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

View more
  5 in total

1.  [Predictive effect of femoral neck strength composite indexes on femoral head collapse in non-traumatic osteonecrosis of femoral head].

Authors:  Tianye Lin; Peng Yang; Kaishen Cai; Ziqi Li; Fengxiang Pang; Qingwen Zhang; Wei He; Qiushi Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-08-15

2.  Bone turnover markers may predict the progression of osteonecrosis of the femoral head in aged males.

Authors:  Zhenyu Shi; Hongting Jin; Quanwei Ding; Jun Ying; Ping-Er Wang; Peijian Tong; Bangjian He
Journal:  Ann Transl Med       Date:  2019-11

3.  1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas.

Authors:  Avishek K Singh; Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Edwin Takahashi; Elazer R Edelman; Hyunjoon Joon Kong; Thanila Macedo; Ravinder J Singh; Matthew W Urban; Rajiv Kumar; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2021-02-24       Impact factor: 10.121

4.  Composite indices of femoral neck strength predicts the collapse of steroid-associated osteonecrosis of the femoral head: a retrospective study.

Authors:  Tianye Lin; Kaishen Cai; Peng Yang; Shana WuRi; Weijian Chen; Pan Deng; Ziqi Li; Zhenqiu Chen; Wei He; Qingwen Zhang; Qiushi Wei
Journal:  BMC Musculoskelet Disord       Date:  2022-07-28       Impact factor: 2.562

Review 5.  Oxidative stress: An essential factor in the process of arteriovenous fistula failure.

Authors:  Ke Hu; Yi Guo; Yuxuan Li; Chanjun Lu; Chuanqi Cai; Shunchang Zhou; Zunxiang Ke; Yiqing Li; Weici Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.